高级检索
当前位置: 首页 > 详情页

Validating scores predicting atrial fibrillation recurrence post catheter ablation in patients with concurrent atrial fibrillation and pulmonary diseases.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China [2]National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Trauma Center, Peking University People’s Hospital, Beijing, China [3]Department of Geriatrics, Beijing Huaxin Hospital, Tsinghua University, Beijing, China [4]Emergency Department of China-Japan Friendship Hospital, Beijing, China [5]Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain [6]Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University, Beijing, China [7]Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
出处:
ISSN:

关键词: Pulmonary diseases (PDs) catheter ablation atrial fibrillation recurrence the BASE-AF2 score

摘要:
Several scores were available for predicting atrial fibrillation (AF) recurrence post radiofrequency ablation. However, the role of different scores predicting AF recurrence after ablation in patients with concurrent AF and pulmonary diseases (PDs) remained obscure. Herein, we aimed to investigate their predicting values and differences in patients with concurrent AF and PDs. From January 2008 to April 2015, 304 patients with concurrent AF and PDs treated with catheter ablation were divided into 2 groups according to whether they experienced AF recurrence in our centers. Factors related with AF recurrence were explored using Cox regression and scores predicting recurrent AF were compared in these patients using ROC curves. During a median of 6-month of follow-up, factors correlating with late AF recurrence included heart failure (HF) history [hazard ratio (HR): 2.79; 95% confidence interval (CI): 1.49-5.22, P=0.001], current smoking (1.73; 1.13-2.68, P=0.01) and early AF recurrence (3.85; 95% CI: 2.62-5.66, P<0.001) according to univariate Cox regression analysis. When analyzed using multivariate Cox model, HF history (2.21; 1.12-4.37, P=0.02), hypertension history (1.54; 1.02-2.33, P=0.04) and early AF recurrence (3.90; 2.60-5.85, P<0.001) were related to late AF recurrence. The BASE-AF2 score had higher c-index than the MB-LATER, APPLE, CHADS2, CHA2DS2-VASc, CAAP-AF and HATCH scores when compared using ROC curves analysis (all P<0.05). The optimal point for predicting AF recurrence of the BASE-AF2 score in the ROC analysis was 1 point with sensitivity of 69.03% and specificity of 60.21%. The predicting AF recurrence value of BASE-AF2 score was superior to MB-LATER, APPLE, CHADS2, CHA2DS2-VASc, CAAP-AF and HATCH scores in patients with concurrent AF and PDs, which can be an effective and helpful score for making AF treatment decisions.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务
最新[2025]版:
JCR分区:
出版当年[2019]版:
Q3 HEALTH CARE SCIENCES & SERVICES
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China [*1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1, Dong Jiao Min Xiang Street, Dongcheng District, Beijing 100730, China.
通讯作者:
通讯机构: [1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China [7]Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China [*1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1, Dong Jiao Min Xiang Street, Dongcheng District, Beijing 100730, China. [*2]Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23410 今日访问量:0 总访问量:1276 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)